Andy Childers is a founding partner of Childers, Schlueter & Smith (CSS) in Atlanta, Georgia. He represents individuals nationwide in mass tort litigation involving dangerous pharmaceutical products and medical devices.
After a thorough investigation, the U.S. Food and Drug Administration (FDA) has requested that manufacturers immediately withdraw all prescription and over-the-counter (OTC) ranitidine medications, commonly known by the brand name Zantac, from the market.
You might be familiar with Pradaxa—a blood-thinning medication that is used to prevent blood clots and strokes in heart arrhythmia patients and manufactured by Boehringer Ingelheim Pharmaceuticals Incorporated (BIPI). What you might not be aware of are the claims that their product marketing was mis
The U.S. District Court in the Eastern District of Louisiana has started the process of selecting 40 cases for the bellwether trial pool. As required by an order dated December 17, 2015, the parties in the Xarelto multidistrict litigation (MDL) have selected 10 cases for…
The Judicial Panel on Multidistrict Litigation consolidated 15 federally filed morcellator cases on Thursday for pre-trial discovery and trial work up. The request for the Morcellator MDL was made by Plaintiffs in an effort to streamline the litigation and fast track the efficient handling of the…
A lawsuit filed last week in state court in Philadelphia, Pennsylvania alleges that Xarelto’s recommended dosage doesn’t work for as long as is represented by the manufacturer, Janssen Pharmaceuticals and Bayer HealthCare. It is believed to be the first in the nation to allege that…
The number of lawsuits claiming injuries associated with Xarelto continues to grow in the U.S., and regulators in Canada recently announced a safety review into reports of liver injuries connected with Xarelto use. The August 26 Health Canada safety review cites numerous reports of liver…
According to a study conducted by researchers for Johns Hopkins Bloomberg School of Public Health and George Washington University that was published on April 24, 2015 in the British Medical Journal, Xarelto may present double warfarin’s risk of serious gastrointestinal bleeds, and Pradaxa may incre
The U.S. Food and Drug Administration (FDA) has rejected three attempts by Johnson & Johnson to expand the approval of its anti-blood clotting drug, Xarelto, according to a report in the Wall Street Journal. Xarelto is approved as a preventative medicine for patients with pulmonary…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) is being asked to centralize approximately two dozen Xarelto lawsuits before one judge in the Southern District of Illinois. The cases are currently spread across the U.S. in several different U.S. District Courts. Consolidating them is expe
The new generation anticoagulant Xarelto is the subject of a wrongful death lawsuit filed last month by the family of a Vermont man who died on August 1, 2012, as a result of a fatal brain hemorrhage.
An Atlanta woman died on August 10, 2007 after eating raw oysters at a Spondivit’s Seafood & Steaks in south Atlanta. The 52 year old woman, whose name has not been released, became infected with Vibrio vulnificus, a bacteria known to contaminate shellfish harvested from the Gulf of Mexico in warm s
A California company has recalled bags of baby carrots because they may be contaminated with Shigella bacteria. The carrots are distributed in Georgia, Florida, California, Colorado, Arizona, Nevada, New Mexico, Oregon and Washington.According to the CDC:Most who are infected with Shigella develop d